Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | GLA | P06280 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18253876 | 0.83 | KDM4E (0.35) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL18372104 | 0.82 | ALDH1A1 (0.48) | ALDH1A1MAPTHPGDAHRHSD17B10 | |
| SCHEMBL18372066 | 0.80 | ALDH1A1 (0.37) | ALDH1A1HPGDAHRHSD17B10L3MBTL1 | |
| SCHEMBL9927330 | 0.80 | MAPT (0.53) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL18372058 | 0.80 | MAPT (0.41) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL18372101 | 0.79 | CYP1A2 (0.38) | KDM4EALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL18372135 | 0.79 | HPGD (0.36) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL18372037 | 0.78 | MAPT (0.49) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL18372071 | 0.78 | NPSR1 (0.41) | KDM4EALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL18372040 | 0.78 | MAPT (0.42) | KDM4EALDH1A1MAPTHPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | PIEZO1, TERT, TPR | KDM4E 1806/4885ALDH1A1 1102/4885MAPT 1255/4885 |
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | PIEZO1, TERT, TPR | KDM4E 1806/4885ALDH1A1 1102/4885MAPT 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.